| SD |
mean arterial blood pressure |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
arterial blood pressure trait |
male |
days
| 6 |
|
86.0 |
mmHg |
4.0 |
9.8 |
vascular transducer tipped catheter |
1.0 |
sham ACF |
2 |
days |
|
|
|
98815 |
2160 |
| SD |
body weight |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
body mass |
female |
days
| 13 |
|
283.6 |
g |
3.8 |
13.7 |
body weighing method |
0.0 |
unx |
97 |
days |
|
|
|
100632 |
2499 |
| SD |
serum creatinine level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
days
| 13 |
|
1.65 |
mg/dl |
0.14 |
0.5 |
serum creatinine analysis |
0.0 |
unx |
97 |
days |
|
|
|
100637 |
2499 |
| SD |
creatinine clearance |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
glomerular filtration trait |
female |
days
| 13 |
|
0.3 |
ml/min |
0.03 |
0.11 |
serum creatinine analysis |
0.0 |
unx |
97 |
days |
|
|
|
100642 |
2499 |
| SD |
serum interleukin-4 level |
vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood interleukin-4 amount |
not specified |
days
| 4 |
|
0.14 |
ug/l |
0.01 |
0.01 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
error not defined |
|
105411 |
3015 |
| SD |
left ventricular end-systolic blood pressure |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricular blood pressure trait |
male |
days
| 6 |
|
64.0 |
mmHg |
3.0 |
7.35 |
vascular transducer tipped catheter |
1.0 |
sham ACF |
2 |
days |
|
|
|
98839 |
2160 |
| SD |
maximum rate of positive change in left ventricular blood pressure |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricular blood pressure trait |
male |
days
| 6 |
|
8231.0 |
mmHg/s |
423.0 |
1036.13 |
vascular transducer tipped catheter |
1.0 |
sham ACF |
2 |
days |
|
|
|
98887 |
2160 |
| SD |
maximum rate of negative change in left ventricular blood pressure |
artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricular blood pressure trait |
male |
days
| 6 |
|
-6032.0 |
mmHg/s |
387.0 |
947.95 |
vascular transducer tipped catheter |
1.0 |
ACF |
2 |
days |
|
|
|
98890 |
2160 |
| SD |
aqueous humor uptake index of verapamil |
tritiated verapamil (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) |
Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. |
REQUEST NEW TERM (00:0000000) |
male |
35.0 days-49.0 days |
3 |
|
8.46 |
% |
0.61 |
1.06 |
liquid scintillation counting |
0.0 |
carotid injection |
15 |
|
sec post excision |
verapamil uptake index |
aqueous humor molecular composition trait |
106138 |
3028 |
| SD |
left ventricular end-diastolic blood pressure |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricular blood pressure trait |
male |
days
| 6 |
|
3.0 |
mmHg |
1.0 |
2.45 |
vascular transducer tipped catheter |
1.0 |
sham ACF |
2 |
days |
|
|
|
98827 |
2160 |
| SD |
left ventricular end-systolic blood pressure |
artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricular blood pressure trait |
male |
days
| 6 |
|
56.0 |
mmHg |
3.0 |
7.35 |
vascular transducer tipped catheter |
1.0 |
ACF |
2 |
days |
|
|
|
98838 |
2160 |
| SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
days
| 6 |
g/g*103 |
2.3 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
sham ACF |
2 |
days |
|
|
|
98875 |
2160 |
| SD |
serum interleukin-9 level |
vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood interleukin-9 amount |
not specified |
days
| 4 |
|
0.1 |
ug/l |
0.01 |
0.01 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
error not defined |
|
105415 |
3015 |
| SD |
retinal uptake index of digoxin |
tritiated digoxin (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) |
Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. |
retina molecular composition trait |
male |
35.0 days-49.0 days |
3 |
|
24.0 |
% |
5.8 |
10.05 |
liquid scintillation counting |
0.0 |
carotid injection |
15 |
|
sec post excision |
digoxin uptake index |
|
106117 |
3028 |
| SD |
brain uptake index of quinidine |
tritiated quinidine (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) |
Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. |
brain molecular composition trait |
male |
35.0 days-49.0 days |
3 |
|
2.12 |
% |
0.12 |
0.21 |
liquid scintillation counting |
0.0 |
carotid injection |
15 |
|
sec post excision |
quinidine uptake index |
|
106150 |
3028 |
| SD |
brain uptake index of verapamil |
tritiated verapamil (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) |
Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. |
brain molecular composition trait |
male |
35.0 days-49.0 days |
3 |
|
9.07 |
% |
0.89 |
1.54 |
liquid scintillation counting |
0.0 |
carotid injection |
15 |
|
sec post excision |
verapamil uptake index |
|
106156 |
3028 |
| SD |
brain uptake index of digoxin |
tritiated digoxin (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) |
Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. |
brain molecular composition trait |
male |
35.0 days-49.0 days |
3 |
|
0.99 |
% |
0.35 |
0.61 |
liquid scintillation counting |
0.0 |
carotid injection |
15 |
|
sec post excision |
digoxin uptake index |
|
106153 |
3028 |
| SD |
mean arterial blood pressure |
artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
arterial blood pressure trait |
male |
days
| 6 |
|
72.0 |
mmHg |
2.0 |
4.9 |
vascular transducer tipped catheter |
1.0 |
ACF |
2 |
days |
|
|
|
98814 |
2160 |
| SD |
intestine trypsin level |
vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
intestine trypsin amount |
not specified |
days
| 4 |
|
0.17 |
ug/l |
0.01 |
0.01 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
error not defined |
|
105419 |
3015 |
| SD |
heart rate |
artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
days
| 6 |
|
420.0 |
beats/min |
14.0 |
34.29 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
2 |
days |
|
|
|
98801 |
2160 |
| SD |
maximum rate of negative change in left ventricular blood pressure |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricular blood pressure trait |
male |
days
| 6 |
|
-7197.0 |
mmHg/s |
303.0 |
742.2 |
vascular transducer tipped catheter |
1.0 |
sham ACF |
2 |
days |
|
|
|
98891 |
2160 |
| SD |
heart rate |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
days
| 6 |
|
380.0 |
beats/min |
10.0 |
24.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
2 |
days |
|
|
|
98802 |
2160 |
| SD |
serum parathyroid hormone level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood parathyroid hormone amount |
female |
days
| 13 |
|
3496.0 |
pg/ml |
862.0 |
3107.99 |
serum parathyroid hormone analysis |
0.0 |
unx |
97 |
days |
|
|
|
100647 |
2499 |
| SD |
left ventricular end-diastolic blood pressure |
artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricular blood pressure trait |
male |
days
| 6 |
|
13.0 |
mmHg |
2.0 |
4.9 |
vascular transducer tipped catheter |
1.0 |
ACF |
2 |
days |
|
|
|
98826 |
2160 |
| SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
days
| 6 |
g/g*103 |
2.6 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
1.0 |
ACF |
2 |
days |
|
|
|
98874 |
2160 |
| SD |
maximum rate of positive change in left ventricular blood pressure |
artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricular blood pressure trait |
male |
days
| 6 |
|
8259.0 |
mmHg/s |
325.0 |
796.08 |
vascular transducer tipped catheter |
1.0 |
ACF |
2 |
days |
|
|
|
98886 |
2160 |
| SD |
retinal uptake index of quinidine |
tritiated quinidine (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) |
Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. |
retina molecular composition trait |
male |
35.0 days-49.0 days |
3 |
|
212.0 |
% |
13.0 |
22.52 |
liquid scintillation counting |
0.0 |
carotid injection |
15 |
|
sec post excision |
quinidine uptake index |
|
106114 |
3028 |
| SD |
retinal uptake index of verapamil |
tritiated verapamil (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) |
Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. |
retina molecular composition trait |
male |
35.0 days-49.0 days |
3 |
|
336.0 |
% |
7.0 |
12.12 |
liquid scintillation counting |
0.0 |
carotid injection |
15 |
|
sec post excision |
verapamil uptake index |
|
106120 |
3028 |
| SD |
aqueous humor uptake index of quinidine |
tritiated quinidine (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) |
Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. |
REQUEST NEW TERM (00:0000000) |
male |
35.0 days-49.0 days |
3 |
|
5.95 |
% |
0.38 |
0.66 |
liquid scintillation counting |
0.0 |
carotid injection |
15 |
|
sec post excision |
quinidine uptake index |
aqueous humor molecular composition trait |
106132 |
3028 |
| SD |
serum total immunoglobulin E level |
vehicle control condition then acetic acid (for 0 hours) then physical restraint in tube type rodent restrainer (for 2 hours) then fasting (for 1 days) |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood immunoglobulin E amount |
not specified |
days
| 4 |
|
0.2 |
ug/l |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
0.0 |
|
|
|
|
error not defined |
|
105407 |
3015 |